IP Library Granted Patent US 8,809,276
Granted Patent B2
US 8,809,276 · App. 13/984,568 · Granted Aug 19, 2014

Activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,809,276
App. No.
13/984,568
Granted
Aug 19, 2014
Kind
B2
Abstract

New peptides activating extracellular matrix protein synthesis in the skin, a cosmetic composition that includes such peptides as an active agent, and cosmetic care methods intended to delay or treat cutaneous signs of aging and photoaging by applying such peptides and/or cosmetic compositions are described.

Claims (52)

1. A peptide consisting of a peptide sequence:

(SEQ ID NO: 1):

Ala-Pro-Ala-Gly-Pro-NH 2 ,

(SEQ ID NO: 2):

Val-Pro-Ala-Gly-Pro-NH 2 ,

(SEQ ID NO: 3):

Val-Pro-Gly-Gly-Pro-NH 2 ,

(SEQ ID NO: 5):

Gly-Pro-Ala-Gly-Pro-NH 2 ,

and

(SEQ ID NO: 6):

Lys-Gly-Ala-Pro-Gly-Gly-Pro-Asn-Tyr-NH 2 .

2. The peptide of claim 1 , wherein the peptide is solubilized in one or more physiologically acceptable solvents selected from the group consisting of water, glycerol, ethanol, propanediol, butylene glycol, dipropylene glycol, the ethoxylated or propoxylated diglycols, the cyclic polyols, and mixtures of these solvents.

3. A cosmetic composition comprising:

in a physiologically acceptable medium, a peptide consisting of at least one of the following peptide sequences:

(SEQ ID NO: 1):

Ala-Pro-Ala-Gly-Pro-NH 2 ,

(SEQ ID NO: 2):

Val-Pro-Ala-Gly-Pro,

(SEQ ID NO: 3):

Val-Pro-Gly-Gly-Pro-NH 2 ,

(SEQ ID NO: 5):

Gly-Pro-Ala-Gly-Pro-NH 2 ,

and

(SEQ ID NO: 6):

Lys-Gly-Ala-Pro-Gly-Gly-Pro-Asn-Tyr-NH 2 ,

as an active agent activating extracellular matrix protein synthesis in the skin.

4. The composition of claim 3 , wherein said peptide is present at a concentration of between 0.0005 and 500 mg/kg with respect to the total weight of the final composition.

5. The composition of claim 3 , wherein the composition is a topical composition comprising a delivery vehicle selected from the group consisting of an aqueous, hydro-alcoholic or oily solution; an oil-in-water or a water-in-oil emulsion or multiple emulsions; aqueous or anhydrous gel, colloid, cream, suspension, powder, lotion, milk, serum, pomade, paste, foam, aerosol or stick.

6. The composition of claim 3 , further comprising at least one other active agent selected from the group consisting of vitamin C, B-group vitamins, dehydroepiandrosterone (DHEA), phytosterols, salicylic acid, retinoids, flavonoids, sugar amines, azoles, metal salts, and peptide extracts of plant origin.

7. The peptide of claim 1 , wherein the peptide is the sequence SEQ ID NO: 5.

8. The composition of claim 4 , wherein said peptide is present at a concentration of between 0.01 and 5 mg/kg with respect to the total weight of the final composition.

9. A method for cosmetic treatment of skin, the method comprising:

applying a composition comprising:

one or more peptides consisting of a peptide sequence selected from the group consisting of:

(SEQ ID NO: 1):

Ala-Pro-Ala-Gly-Pro-NH 2 ,

(SEQ ID NO: 2):

Val-Pro-Ala-Gly-Pro-NH 2 ,

(SEQ ID NO: 3):

Val-Pro-Gly-Gly-Pro-NH 2 ,

(SEQ ID NO: 5):

Gly-Pro-Ala-Gly-Pro-NH 2 ,

and

(SEQ ID NO: 6):

Lys-Gly-Ala-Pro-Gly-Gly-Pro-Asn-Tyr-NH 2 ,

and a physiologically acceptable medium.

10. The method of claim 9 , wherein applying the composition includes applying an effective amount for increasing the synthesis of type-I and type-III collagens and fibronectin by the fibroblasts.

11. The method of claim 9 , wherein applying the composition includes applying an effective amount for increasing the expression of hyaluronic acid by skin fibroblasts and keratinocytes.

12. The method of claim 9 , wherein applying the composition includes applying an effective amount for delaying the appearance of or reduces senescence of skin cells.

13. The method of claim 9 , wherein applying includes topically applying the composition to the skin.

14. The method of claim 9 , wherein applying the composition includes applying an effective amount for treating cutaneous signs of aging and photoaging.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2013
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 030976/0250 →